AVITA Medical, Inc. ($RCEL)

Hello, and welcome to the 2026 Annual Meeting of Stockholders of AVITA Medical, Inc. Please note that today's meeting is being recorded. [Operator Instructions] Following the formal meeting, there will be a question-and-answer session addressing questions strictly related to today's meeting. You may submit questions at any time by clicking on the Message icon. It is now my pleasure to hand today's meeting over to Jan Stern Reed, Chair of AVITA Medical's Board of Directors.

Thank you, Ryan. Good afternoon, and welcome to the 2026 Annual Stockholders Meeting of AVITA Medical, Inc. It is 3:00 p.m. Pacific Daylight Time on June 3, 2026 and 8 a.m. Australian Eastern Standard Time on June 4, 2026, and the meeting will now come to order. Please note that today's meeting is being held exclusively by way of live webcast with no physical meeting location. I point you to the agenda for today's meeting in the Meeting Documents section of the virtual meeting portal. This annual meeting is being conducted in accordance with the company's bylaws and the written notice provided to all stockholders. And for a smooth and efficient meeting, we kindly ask all participants to follow along with the agenda and to abide by the guidelines provided for today's meeting. Pursuant to our bylaws, you may submit pertinent questions at any time during today's meeting by using the field provided on the virtual meeting portal. Questions related to today's meeting content will be addressed during the Q&A session after we conclude the formal business of the meeting. Allow me to thank you on behalf of our Board of Directors for attending today's meeting and for your continued support of the company. I am pleased to introduce our directors attending today's meeting, including myself as Chair of the Board; Cary Vance, Chief Executive Officer; Professor Suzanne Crowe, Jeremy Curnock-Cook, Robert McNamara, Dr. Michael Tarnoff and Joseph Woody. Also present are our executive officers, David O'Toole, the company's Chief Financial Officer; and Nicole Kelsey, Chief Legal and Compliance Officer and Corporate Secretary. In accordance with our bylaws, I will preside over today's meeting and Nicole Kelsey will serve as the Secretary of this meeting. Also in event today are representatives from Grant Thornton LLP, our independent registered public accounting firm as well as representatives from Computershare Limited, our U.S. transfer agent and Computershare Investor Services Limited, our share registry for shares held in the form of CDIs on the Australian Securities Exchange. Before we move into the formal business of today's meeting, I'll ask Nicole to confirm that proper notice of this annual meeting has been given to all stockholders.

Thanks, Jan. The Board set April 9, 2026, is the record date for this annual meeting. I confirm that the company has received affidavits attesting to proper notice and the availability of proxy materials to all stockholders. Additionally, an annual report on Form 10-K for the fiscal year ended December 31, 2025, including certified financial statements, has been made available to all stockholders entitled to vote at today's meeting.

Thank you, Nicole. With proper notice confirmed, I will now formally appoint the Inspector of Elections. Brian Heffernan of Computershare Limited is serving as our Independent Inspector of Elections for this meeting. The list of holders of record of the company's common stock -- sorry about that. Bear with me. Okay. The list of the holders of -- the list of holders of record of the company's common stock as of the record date has been prepared. For the duration of today's meeting, this list of stockholders will be available for inspection by any stockholder of record upon request. Nicole, please provide your report on the number of shares represented at the meeting, so we may formally establish quorum.

Sure thing, Jan. I hereby confirm that as of the record date, there were a total of 30,776,689 shares of common stock, which includes the underlying shares of common stock represented by CDIs listed on the Australian Stock Exchange that were outstanding and entitled to vote as of that record date. The Inspector of Elections has confirmed that proxies representing more than 50% of such shares entitled to vote at today's meeting have been received. Therefore, a quorum is present.

Great. Thank you, Nicole. With a quorum established, we can now proceed to the formal presentation and consideration of the proposals described in our proxy statement. We have the following proposals presented for your consideration. Proposal 1, election of Directors. Proposal 2, ratification of appointment of our independent registered public accounting firm, Grant Thornton. Proposal 3, approval of an increase to the Non-Executive Director cash fee pool. Proposals 4 through 11, approval of equity awards to Non-Executive Directors pursuant to ASX Listing Rule 10.11. Proposal 12, advisory vote on executive compensation known in the U.S. as the Say-on-Pay proposal. Proposal 13, advisory vote on the frequency of Say-on-Pay proposals. Proposal 14, approval of the issuance of warrants to prospective Credit Holdings LP. Proposal 15, approval by way of special resolution of an increase to the placement capacity of the company for purposes of ASX Listing Rule 7.18. The Board of Directors recommends a vote for all of the nominees listed in Proposal 1 and a vote for Proposals 2 through 15, except for their respective personal interests and a proposal causes them to abstain. For example, on a vote regarding their own fiscal year '26 annual equity award. No other business has been properly presented for consideration at this meeting as required by our bylaws. The polls for voting are now open. For holders of common stock. If you have already voted by proxy, you do not need to vote again unless you wish to change your vote. However, if you have not yet submitted a proxy and wish to vote on these matters, please take a moment now to complete voting via the virtual meeting portal. CDI holders have previously submitted their voting instructions. [Voting]

Now that everyone has had the opportunity to vote, the polls are now closed. Nicole, can you please provide the preliminary voting results at this time?

Sure thing. As Secretary, I can confirm that as of 12:00 noon Pacific Time today, all 15 proposals received the requisite for votes to pass in this year's meeting.

Great. Thank you. The Inspector of Elections will tabulate the final votes, and the final voting results will be announced through a Form 8-K filing with the U.S. Securities and Exchange Commission, immediately followed by a corresponding lodgement on the Australian Securities Exchange promptly following the close of this meeting. Thank you for attending today's meeting. The formal portion of our Annual Stockholders' Meeting is now adjourned. We encourage all interested shareholders to review Cary Vance's recent armchair chat available in the Events and Presentations section of our Investor Relations site at ir.avitamedical.com. We now invite your questions related strictly to matters covered in today's meeting. Please submit questions via the virtual meeting portal.

Jan, I can confirm that there have been no questions submitted through the virtual meeting portal.

Okay. This concludes AVITA Medical's 2026 Annual Stockholders Meeting. Thank you again for your participation today and for your ongoing support of AVITA Medical.

This concludes the meeting. You may now disconnect.